Lara Clarissa Burg

Lara Clarissa Burg

Auto-generated profile, based on publicly available information

Lara Clarissa Burg

Department of Rheumatology and Clinical Immunology, Clinic of Internal Medicine III, University Hospital of Bonn, Bonn, Germany

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Therapeutic Advances in Musculoskeletal Disease
Verified
Journal Article
Open access
LBLara C. Burg
Lara C. Burg
PKPantelis Karakostas
Pantelis Karakostas
CBCharlotte Behning
Charlotte Behning
PBPeter Brossart
Peter Brossart
TKTanaz A. Kermani
Tanaz A. Kermani
Valentin Sebastian SchäferValentin Sebastian Schäfer
Valentin Sebastian Schäfer
Background: It is known that giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) often occur together. So far, the prevalence of GCA in newly diagnosed PMR patients has not been evaluated in a prospective ultrasound study. Objective: The aim of this study was to assess the prevalence of GCA using vascular ultrasound in patients with newly diagnosed PMR. Design: A consecutive cohort of newly diagnosed PMR patients was prospectively evaluated for the presence of GCA with the use of systematic musculoskeletal and vascular ultrasound examination. Methods: Overall, 60 patients with newly diagnosed PMR were prospectively enrolled. Symptoms and laboratory findings were collected. All patients underwent ultrasound of shoulder and hip joints, and vascular ultrasound evaluating the facial, temporal, carotid, vertebral and axillary arteries. Patients were diagnosed with GCA if they had ultrasound imaging findings of GCA. Patients with PMR (PMR-group) and patients with PMR and GCA (PMR–GCA-group) were compared, and a C-reactive protein (CRP) cut-off value was evaluated. Results: GCA was diagnosed in 28 of 60 PMR patients (46%). The PMR-group consisted of 20 (62.5%) females with a mean age of 69 (±9.9) years, while the PMR–GCA-group consisted of 11 (39.3%) females with a mean age of 74 (±8.4) years. In 13 of 28 patients (46%) in the PMR–GCA-group, GCA was subclinical and only diagnosed by ultrasound. The PMR–GCA-group showed higher values of joint effusion and significantly higher CRP values. A CRP cut-off value of 26.5 mg/litre (reference range 0–5 mg/litre) yielded a sensitivity of 66% with a specificity of 73% for GCA. Conclusion: GCA was found in 46% of newly diagnosed PMR patients; 22% of the patients with PMR had asymptomatic GCA. Joint effusions were higher in the PMR–GCA-group, with significant results for the hip joint. A CRP cut-off value of ⩾26.5 mg/litre in PMR can help in the identification of subclinical GCA.

17 May 2024 in Rheumatology
Verified
Journal Article
Closed access
PDF file
SPSimon Michael Petzinna
Simon Michael Petzinna
LBLara C Burg
Lara C Burg
CBClaus-Juergen Bauer
Claus-Juergen Bauer
PKPantelis Karakostas
Pantelis Karakostas
JTJan H Terheyden
Jan H Terheyden
VSValentin S Schäfer
Valentin S Schäfer
The objective of this study was to prospectively evaluate the diagnostic efficacy of transorbital ultrasound (TOS) in patients newly diagnosed with giant cell arteritis (GCA), presenting with visual symptoms. Patients with newly diagnosed, untreated GCA were examined using TOS, assessing central retinal artery flow velocity [peak systolic velocity (PSV), end-diastolic velocity (EDV), resistance index (RI)], and optic nerve diameter (OND). Vascular ultrasound was conducted to evaluate the superficial temporal arteries, their branches, facial, axillary, carotid, and vertebral arteries. We enrolled 54 GCA patients, 27 with visual symptoms, and 27 healthy controls. Eyes of GCA patients with visual symptoms demonstrated significantly lower PSV and EDV (PSV: β=-1.91; p=0.029; EDV: β=-0.57; p=0.032) and significantly elevated OND (β = 0.79; p=0.003) compared with controls. RI did not significantly differ from controls (β=-0.06, p=0.129). Vascular ultrasound identified an average of 8.7 (SD ± 2.8) pathological vessels per GCA patient. A significant negative association was observed between the number of affected vessels and both PSV (p=0.048) and EDV (p=0.040). No association was found with RI (p=0.249), while a positive significant association was noted with OND (p<0.001). This study pioneers the application of TOS to assess structural eye changes in newly diagnosed, untreated GCA patients with visual symptoms. Our findings suggest reduced central retinal artery flow and increased optic nerve diameter as potential biomarkers for serious ocular involvement in GCA. The detected association between internal and external carotid artery involvement indicates a common pathophysiological mechanism underlying systemic and ocular manifestations of GCA.

1 February 2024 in Rheumatology
Verified
Journal Article
Closed access
PDF file
Valentin Sebastian SchäferValentin Sebastian Schäfer
Valentin Sebastian Schäfer
CDChristian Dejaco
Christian Dejaco
PKPantelis Karakostas
Pantelis Karakostas
CBCharlotte Behning
Charlotte Behning
PBPeter Brossart
Peter Brossart
LBLara C Burg
Lara C Burg
Objectives: Ultrasound is a standard tool to diagnose giant cell arteritis (GCA). Until now, only a few studies have investigated the role of ultrasound in the follow-up of GCA. The aim of this study was to assess the changes in the intima–media thickness (IMT), total number of affected arteries and provisional OMERACT GCA ultrasonography score (OGUS) in a 12-months follow-up period. Methods: Patients with newly diagnosed GCA were prospectively enrolled. Ultrasound examinations of facial, temporal, carotid, vertebral and axillary arteries were performed at baseline, after 3, 6, 9 and 12 months. Changes of IMT, total number of affected arteries and OGUS values were evaluated. In a subgroup of patients, exams were conducted weekly in the first 100 days. Results: Fifty patients were enrolled and 36 completed the follow-up. Significant reductions in IMT, total number of affected arteries and OGUS were observed. Eighteen patients presented to weekly exams. The mean IMT of the axillary artery normalized after 7 days, while IMT of the common temporal artery normalized after 50 days. The mean OGUS values were below 1 after 6 months. There were no differences in IMT changes between GCA patients with or without PMR or between those with and without additional tocilizumab treatment. A relapse occurred in four patients. At relapse, mean IMT and OGUS were higher as compared to the preceding assessment. No predictive values indicating a relapse were identified. Conclusion: Vascular ultrasound is sensitive to change in GCA. The presence of PMR or treatment with tocilizumab did not affect IMT decrease.

11 February 2025 in Rheumatology International
Verified
Journal Article
Open access
PDF file
SPSimon Michael Petzinna
Simon Michael Petzinna
JTJan Henrik Terheyden
Jan Henrik Terheyden
LBLara C. Burg
Lara C. Burg
CBClaus-Juergen Bauer
Claus-Juergen Bauer
PKPantelis Karakostas
Pantelis Karakostas
Valentin Sebastian SchäferValentin Sebastian Schäfer
Valentin Sebastian Schäfer
Dear Editor, Giant cell arteritis (GCA) can lead to devastating ophthalmic complications, including sudden complete loss of vision due to anterior ischemic optic neuropathy (AION) secondary to inflammation and occlusion of the short posterior ciliary arteries, which supply the optic nerve head [1, 2]. Ischemia results in retinal changes, such as nerve fiber layer thickening, structural loss and optic disc edema [3, 4]. Assessing ophthalmic involvement in GCA remains challenging. Non-invasive optical coherence tomography angiography (OCTA) of the eye enables us to visualize the retinal and choroidal microcirculation [5, 6]. Additionally, we have recently shown that transorbital ultrasound (TOS) reveals changes in the ocular perfusion of symptomatic eyes in GCA patients [7]. Building on this cohort, we present the first study comparing vascular ultrasound, TOS, and OCTA findings in newly diagnosed GCA patients. The study enrolled newly diagnosed and untreated GCA patients from the Rheumatology Department at the University Hospital Bonn, Germany. Diagnoses were made by a board-certified rheumatologist with patients further meeting the ACR-EULAR classification criteria [8] following ethics approval (ethics committee of the University Hospital Bonn, reference number: 097/18, october 2018). Demographic, clinical, and laboratory data were assessed. Each patient underwent a comprehensive ultrasound examination of superficial temporal, facial, axillary, carotid, and vertebral arteries, along with TOS using a Logiq S8 (2018; GE Healthcare; 6-15 MHz/ 8-18 MHz probes). Flow velocities of the central retinal artery (CRA), including peak systolic velocity (PSV), end diastolic velocity (EDV), resistance index (RI), and optic nerve diameter (OND) were assessed as described previously [7]. OCTA imaging was performed in one eye per participant, prioritizing

20 March 2021 in BMC Medical Imaging
Verified
Journal Article
Open access
PDF file
LBLara Clarissa Burg
Lara Clarissa Burg
WSWolfgang Andreas Schmidt
Wolfgang Andreas Schmidt
PBPeter Brossart
Peter Brossart
KRKatharina Isabell Reinking
Katharina Isabell Reinking
FSFranziskus Maria Schützeichel
Franziskus Maria Schützeichel
Valentin Sebastian SchäferValentin Sebastian Schäfer
Valentin Sebastian Schäfer
Background: Giant cell arteritis (GCA) is the most common form of systemic vasculitis in persons aged 50 years and older. Medium and large vessels, like the temporal and axillary arteries, are commonly affected. Typical symptoms are headache, scalp tenderness, jaw claudication and ophthalmological symptoms as loss of visual field, diplopia or amaurosis due to optic nerve ischemia. Tongue pain due to vasculitic affection of the deep lingual artery can occur and has so far not been visualized and followed up by modern ultrasound. Case presentation: We report the case of a 78-year-old woman with typical symptoms of GCA, such as scalp tenderness, jaw claudication and loss of visual field, as well as severe tongue pain. Broad vasculitic affection of the extracranial arteries, vasculitis of the central retinal artery and the deep lingual artery could be visualized by ultrasound. Further did we observe a relevant decrease of intima-media thickness (IMT) values of all arteries assessed by ultrasound during follow-up. Especially the left common superficial temporal artery showed a relevant decrease of IMT from 0.49 mm at time of diagnosis to 0.23 mm on 6-months follow-up. This is the first GCA case described in literature, in which vasculitis of the central retinal artery and the lingual artery could be visualized at diagnosis and during follow-up using high-resolution ultrasound. Conclusion: High-resolution ultrasound can be a useful diagnostic imaging modality in diagnosis and follow-up of GCA, even in small arteries like the lingual artery or central retinal artery. Ultrasound of the central retinal artery could be an important imaging tool in identifying suspected vasculitic affection of the central retinal artery.

1 June 2020 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
LBL. C. Burg
L. C. Burg
PBPeter Brossart
Peter Brossart
KRK. I. Reinking
K. I. Reinking
RFR. P. Finger
R. P. Finger
CBCharlotte Behning
Charlotte Behning
Valentin Sebastian SchäferValentin Sebastian Schäfer
Valentin Sebastian Schäfer
Background: Giant cell arteritis (GCA) is the most common form of systemic vasculitis in patients aged 50 years and older.1 Visual symptoms such as amaurosis, diplopia, temporary or permanent visual field loss secondary to optic nerve ischemia are common manifestations.2 The value of vascular ultrasound of extra-ocular vessels in diagnosing GCA is well established.3 However, the role of transocular ultrasound of the central retinal artery in GCA patients has not yet been established. Objectives: To identify changes in flow velocities of the central retinal artery in GCA patients with visual symptoms and controls with transocular high resolution ultrasound. Methods: Prospective analysis of GCA patients with visual symptoms and controls. Ultrasound of the central retinal artery was performed in 18 newly diagnosed consecutive GCA patients with visual symptoms (GCA-group) and 25 controls without ocular pathology. Visual symptoms included amaurosis, diplopia and temporary or permanent visual field loss. For each eye, peak systolic values (PS) and end diastolic values (ED) were recorded. Furthermore, the resistance index of each central retinal artery was measured. Results: Twenty-one of 36 eyes of 18 GCA patients were affected. Therefore 21 central retinal were measured. The control group consisted of 50 central retinal arteries of 25 eye-healthy individuals. The mean age and gender distribution of the GCA-group were 75.6 years (SD± 8.1) with eight females (44 %) and 67 years (SD± 8.9) with twelve females (48%) in the control group. The mean flow velocity of the central retinal artery was PS 12.2 cm/s (SD± 3.5) and ED 3.7 cm/s (SD± 1.2) in the GCA group and PS 14.4 cm/s (SD± 3.2) and ED 5.1 cm/s (SD± 1.6) in the control group. The mean RI was 0.9 (SD± 0.3) in the GCA group and 0.8 (SD± 0.3) in the control group. Mean reduction in flow velocity in the GCA-group was PS 2.1 cm/s (p= 0.039) and ED 1.4 (p= 0.0004) cm/s, while the RI was increased by 0.14 (p= 0.077). The results for PS and ED measurements were statistically significant, while the results for RI were not significant. Conclusion: In GCA patients with ocular symptoms, a reduction of flow velocities of the central retinal artery compared to the eye-healthy control group was found. Results for PS and ED were significant. There seems to be a trend for decreased flow velocities in coexistence with visual symptoms in patients with GCA. References: [1]Warrington KJ, Matteson EL. Management guidelines and outcome measures in giant cell arteritis (GCA). Clin Exp Rheumatol 2007;25:137–41. [2]Chean CS, Prior JA, Helliwell T, et al. Characteristics of patients with giant cell arteritis who experience visual symptoms. Rheumatol Int 2019;39:1789–96. [3]Dejaco C, Ramiro S, Duftner C, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis 2018;77:636–43 Transocular ultrasound of an affected eye in giant cell arteritis with reduced flow velocities and increased resistance index. Disclosure of Interests: None declared